Amyris expands farnesene processing

Emeryville, Calif.-based Amyris Inc. announced that it has signed definitive agreements with Glycotech, Inc. and Salisbury Partners, LLC for Glycotech to provide chemical processing at Salisbury’s Leland, N.C., U.S.A., facility to convert Amyris’ Biofene, or renewable farnesene, into finished products for a wide range of applications. The parties expect that Amyris’ No Compromise squalane will be the first Amyris product processed for commercial sale in the facility. “We are excited to access this facility to perform our own chemical processing of farnesene into our target 2011 end products of squalane and lubricant,” said John Melo, CEO of Amyris. (January 10, 2011)